Wockhardt Limited (NSEI: WOCKPHARMA)
Health Care · Pharmaceuticals · IN
Rs1,886.30
-2.40% today · +27.5% 1Y
Wockhardt Limited (NSEI: WOCKPHARMA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.20B and employs 2,564 people.
Over the last twelve months the share price has gained 27.5%, trading between 1.09K and 2.42K.
Tweenvest scores Wockhardt Limited across four factors: quality 60/100, value 43/100, growth 51/100. Its strongest factor is quality.
WOCKPHARMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.20B
- Revenue (TTM)
- $386.35M
- P/E
- 74.89
- EPS
- 25.19
- Dividend yield
- —
- Beta (5Y)
- 0.99
- 52-week high
- Rs2,422.30
- 52-week low
- Rs1,086.70
- Avg volume (3M)
- —
- Shares outstanding
- 162.49M
- Employees
- 2,564
- Next earnings
- —
About Wockhardt Limited
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
- ISIN
- INE049B01025
- Founded
- 1967
- Listed since
- Jul 1, 2002
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,247.70 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.02 | -0.74% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.20 | +0.36% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.10 | +0.19% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.32 | +0.18% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.02 | +0.18% |
Figures last refreshed Aug 18, 2026.